By Jane Koo
The patient-specific nature of autologous cell therapies presents unique challenges that can best be addressed by a middle path between on-site and centralized manufacturing.
Read the full article here: BioSpace
Advanced therapies and technology point to the future for hematological cancers, but access remains a challenge.
Experts from Brazil and around the world participated in debates held at the Einstein venue during the most important global congress in the field....